Pheochromocytoma differential diagnosis: Difference between revisions
No edit summary |
Ahmed Younes (talk | contribs) No edit summary |
||
(7 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Pheochromocytoma]] | |||
{{CMG}}; {{AE}} {{AAM}} {{MAD}} | {{CMG}}; {{AE}} {{AAM}} {{MAD}} | ||
Line 14: | Line 14: | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Investigations | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Investigations | ||
|- | |- | ||
|Pheochromocytoma | |Pheochromocytoma<sup>[[Renal artery stenosis ultrasound#cite note-pmid23457117-1|[1]]][[Pheochromocytoma laboratory findings#cite note-pmid12574179-4|[4]]]</sup> | ||
|Features of [[sympathetic nervous system]]<nowiki/>hyperactivity and include: | |||
* [[Palpitations]] (especially in [[epinephrine]] producing tumors) | * [[Palpitations]] (especially in [[epinephrine]] producing tumors) | ||
* [[Anxiety]] | * [[Anxiety]] | ||
Line 30: | Line 30: | ||
** [[Plasma]] fractionated [[Metanephrine|metanephrines]] | ** [[Plasma]] fractionated [[Metanephrine|metanephrines]] | ||
** 24-hour [[urinary]] fractionated [[Metanephrine|metanephrines]], catecholamines | ** 24-hour [[urinary]] fractionated [[Metanephrine|metanephrines]], catecholamines | ||
** Imaging studies ([[CT scan]], [[Magnetic resonance imaging|MRI]] and iodine-123-meta-iodobenzylguanidine or MIBG scintiscan) | ** Imaging studies ([[CT scan]], [[Magnetic resonance imaging|MRI]] and iodine-123-meta-iodobenzylguanidine or MIBG scintiscan) | ||
* '''Low-risk patients''': | * '''Low-risk patients''': | ||
** 24-hour [[urinary]] fractionated [[catecholamines]] and [[Metanephrine|metanephrines]] | ** 24-hour [[urinary]] fractionated [[catecholamines]] and [[Metanephrine|metanephrines]] | ||
|- | |- | ||
|Pseudopheochromocytoma<ref name="pmid102187452">{{cite journal| author=Mann SJ| title=Severe paroxysmal hypertension (pseudopheochromocytoma): understanding the cause and treatment. | journal=Arch Intern Med | year= 1999 | volume= 159 | issue= 7 | pages= 670-4 | pmid=10218745 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10218745 }}</ref><ref name="pmid10218745">{{cite journal| author=Mann SJ| title=Severe paroxysmal hypertension (pseudopheochromocytoma): understanding the cause and treatment. | journal=Arch Intern Med | year= 1999 | volume= 159 | issue= 7 | pages= 670-4 | pmid=10218745 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10218745 }}</ref><ref name="pmid8824124">{{cite journal| author=Mann SJ| title=Severe paroxysmal hypertension. An automatic syndrome and its relationship to repressed emotions. | journal=Psychosomatics | year= 1996 | volume= 37 | issue= 5 | pages= 444-50 | pmid=8824124 | doi=10.1016/S0033-3182(96)71532-3 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8824124 }}</ref><ref name="pmid17921824">{{cite journal| author=Sharabi Y, Goldstein DS, Bentho O, Saleem A, Pechnik S, Geraci MF et al.| title=Sympathoadrenal function in patients with paroxysmal hypertension: pseudopheochromocytoma. | journal=J Hypertens | year= 2007 | volume= 25 | issue= 11 | pages= 2286-95 | pmid=17921824 | doi=10.1097/HJH.0b013e3282ef5fac | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17921824 }}</ref> | |Pseudopheochromocytoma (idiopathic)<ref name="pmid102187452">{{cite journal| author=Mann SJ| title=Severe paroxysmal hypertension (pseudopheochromocytoma): understanding the cause and treatment. | journal=Arch Intern Med | year= 1999 | volume= 159 | issue= 7 | pages= 670-4 | pmid=10218745 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10218745 }}</ref><ref name="pmid10218745">{{cite journal| author=Mann SJ| title=Severe paroxysmal hypertension (pseudopheochromocytoma): understanding the cause and treatment. | journal=Arch Intern Med | year= 1999 | volume= 159 | issue= 7 | pages= 670-4 | pmid=10218745 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10218745 }}</ref><ref name="pmid8824124">{{cite journal| author=Mann SJ| title=Severe paroxysmal hypertension. An automatic syndrome and its relationship to repressed emotions. | journal=Psychosomatics | year= 1996 | volume= 37 | issue= 5 | pages= 444-50 | pmid=8824124 | doi=10.1016/S0033-3182(96)71532-3 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8824124 }}</ref><ref name="pmid17921824">{{cite journal| author=Sharabi Y, Goldstein DS, Bentho O, Saleem A, Pechnik S, Geraci MF et al.| title=Sympathoadrenal function in patients with paroxysmal hypertension: pseudopheochromocytoma. | journal=J Hypertens | year= 2007 | volume= 25 | issue= 11 | pages= 2286-95 | pmid=17921824 | doi=10.1097/HJH.0b013e3282ef5fac | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17921824 }}</ref> | ||
|Paroxysmal activation of the [[Sympathetic nervous system|sympathetic system]] | |Paroxysmal activation of the [[Sympathetic nervous system|sympathetic system]] may cause: | ||
* Emotional distress | * Emotional distress | ||
* Acute onset of high [[blood pressure]] | * Acute onset of high [[blood pressure]] | ||
* [[Headache]] | * [[Headache]] | ||
* Chest pain | * [[Chest pain]] | ||
* [[Nausea]] | * [[Nausea]] | ||
* [[Palpitation|Palpitations]] | * [[Palpitation|Palpitations]] | ||
Line 51: | Line 51: | ||
* [[Tachycardia]] | * [[Tachycardia]] | ||
| | | | ||
* Increase in plasma [[catecholamines]] between and during attacks | * Increase in plasma [[catecholamines]] between and during attacks | ||
|- | |- | ||
|[[Panic attacks]] | |[[Panic attacks]] | ||
| | | | ||
* Paroxysms of increased [[Sympathetic nervous system|sympathetic activity]] | * Paroxysms of increased [[Sympathetic nervous system|sympathetic activity]] | ||
* Episodes of fear or panic attacks | * Episodes of fear or [[panic attacks]] | ||
* [[Chest]] | * [[Chest pain]] | ||
* [[Headache]] | * [[Headache]] | ||
* [[Palpitations]] | * [[Palpitations]] | ||
Line 64: | Line 64: | ||
* Fear precedes physical symptoms. | * Fear precedes physical symptoms. | ||
| | | | ||
* Patients look anxious | * Patients look anxious | ||
* [[Tachycardia]] | * [[Tachycardia]] | ||
* [[Hypertension]] | * [[Hypertension]] | ||
Line 102: | Line 102: | ||
* High [[triiodothyronine]] (T3) concentration | * High [[triiodothyronine]] (T3) concentration | ||
|- | |- | ||
|[[Renovascular hypertension]] | |[[Renal artery stenosis|Renovascular hypertension]] | ||
| | | | ||
* Common in individuals < 30 years or > 55 years | * Common in individuals < 30 years or > 55 years | ||
Line 257: | Line 257: | ||
* Neck [[Computed tomography|CT]] scan | * Neck [[Computed tomography|CT]] scan | ||
|} | |} | ||
Pheochromocytoma must be differentiated from other adrenal tumors such as [[adrenocortical adenoma]], adrenal [[metastasis]], and [[Cushing's syndrome]]. | |||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px" align="center" | |||
|+ | |||
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Differential Diagnosis}} | |||
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|Clinical picture}} | |||
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|Imagings}} | |||
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|Laboratory tests}} | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |'''Adrenocortica'''l carcinoma | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Mass effect symptoms | |||
* Symptoms related to excess [[glucocorticoid]] | |||
* Symptoms related to excess [[mineralocorticoid]] | |||
* Symptoms related to excess [[androgen]] or [[estrogen]] secretion | |||
| | |||
* Irregular shape | |||
* Non-[[homogeneous]] density because of central areas of low attenuation due to [[tumor]] [[necrosis]] | |||
* [[Tumor]] [[calcification]] | |||
* Diameter usually >4 cm | |||
* Unilateral location | |||
* High unenhanced [[Computed tomography|CT]] attenuation values (>20 HU) | |||
* Non-[[homogeneous]] enhancement on [[Computed tomography|CT]] with [[intravenous]] [[Contrast medium|contrast]] | |||
* Delay in [[contrast medium]] washout (10 minutes after administration of [[contrast]], an absolute [[contrast medium]] washout of less than 50 percent) | |||
* Hypointensity compared with [[liver]] on T1 weighted [[Magnetic resonance imaging|MRI]] and high to intermediate signal intensity on T2 weighted [[Magnetic resonance imaging|MRI]] | |||
* High standardized uptake value (SUV) on [[FDG-PET|FDG]]-[[PET scan|PET-CT]] study | |||
* Evidence of local [[invasion]] or [[Metastasis|metastases]] | |||
| | |||
* [[Androgen|Adrenal androgens]] ([[DHEAS|DHEAS)]] | |||
* [[Androstenedione]] | |||
* Bioavailable [[testosterone]] should be measured in every patient. | |||
* [[17-Hydroxyprogesterone|17-hydroxyprogesterone]] | |||
* Serum [[estradiol]] in men and postmenopausal women | |||
* [[Cortisol level]] | |||
* Fasting serum [[cortisol]] at 8 AM following a 1 mg dose of [[dexamethasone]] at bedtime | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |[[Adrenal adenoma]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Symptoms related to excess [[glucocorticoid]] | |||
* Symptoms related to excess [[mineralocorticoid]] | |||
| | |||
* Round, [[homogeneous]] with sharp margination | |||
* Unilateral with diameter less than 4 cm | |||
* Low unenhanced [[Computed tomography|CT]] attenuation values (<10 HU) | |||
* Rapid [[contrast medium]] washout after administration of contrast | |||
* An absolute [[contrast medium]] washout of more than 50 percent | |||
* [[Chemical shift]]: evidence of [[lipid]] on [[Magnetic resonance imaging|MRI]] | |||
* Isointensity with [[liver]] on both T1 and T2 weighted [[Magnetic resonance imaging|MRI]] sequences | |||
| | |||
* [[Cortisol level]] | |||
* Fasting [[serum]] [[cortisol]] at 8 AM following a 1 mg dose of [[dexamethasone]] at bedtime | |||
* [[Renin]] ([[Plasma renin activity|PRA]]) or plasma renin concentration (PRC): very low in patients with [[primary aldosteronism]], usually less than 1 ng/mL per hour for [[Plasma renin activity|PRA]] and usually undetectable for PRC<ref name="pmid26372319">{{cite journal| author=Manolopoulou J, Fischer E, Dietz A, Diederich S, Holmes D, Junnila R et al.| title=Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassays. | journal=J Hypertens | year= 2015 | volume= 33 | issue= 12 | pages= 2500-11 | pmid=26372319 | doi=10.1097/HJH.0000000000000727 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26372319 }}</ref> | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |[[Cushing's syndrome]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Rapid [[Obesity|weight gain]], particularly of the [[trunk]] and [[face]] with [[limbs]] sparing ([[central obesity]]) | |||
* Proximal [[muscle weakness]] | |||
* A [[round face]] often referred to as a "[[moon face]]" | |||
* Excess [[sweating]] | |||
* [[Headache]] | |||
| | |||
* Imaging may show [[mass]] if presents | |||
| | |||
* 24-hour [[urine]] [[cortisol]] | |||
* Midnight salivary [[cortisol]] | |||
* Low-dose [[dexamethasone]] suppression test; high [[cortisol]] level after the [[dexamethasone]] test is suggestive of [[hypercortisolism]]. | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |[[Pheochromocytoma]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* [[Palpitations]] especially in [[Epinephrine|epinephrine-]]<nowiki/>producing [[Tumor|tumors]]. | |||
* [[Anxiety]] often resembling that of a [[panic attack]] | |||
* [[Sweating]] | |||
* [[Headaches]] occur in 90 % of patients. | |||
* Paroxysmal attacks of [[hypertension]] but some patients have normal [[blood pressure]]. | |||
* It may be [[asymptomatic]] and discovered incidentally after [[Screening (medicine)|screening]] for [[MEN, type 2|MEN]] patients. | |||
| | |||
* Increased [[attenuation]] on non-enhanced [[Computed tomography|CT]] (>20 HU) | |||
* Increased [[mass]] [[vascularity]] | |||
* Delay in [[contrast medium]] washout (10 minutes after administration of [[contrast]], an absolute [[contrast medium]] washout of less than 50 percent) | |||
* High signal intensity on T2 weighted [[Magnetic resonance imaging|MRI]] | |||
* [[Cystic]] and [[hemorrhagic]] changes | |||
* Variable size and may be [[bilateral]] | |||
| | |||
* [[Plasma]] fractionated [[Metanephrine|metanephrines]] | |||
* 24-hour [[urinary]] fractionated [[Metanephrine|metanephrines]] | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |[[Adrenal metastasis]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* [[Symptoms]] and [[signs]] of primary [[malignancy]] especially [[lung cancer]] | |||
* General constitutional symptoms: | |||
**[[Fever]] | |||
**[[Fatigue]] | |||
**[[Weight loss]] | |||
| | |||
* Irregular shape and non-[[homogeneous]] nature | |||
* Tendency to be [[bilateral]] | |||
* High un-enhanced [[Computed tomography|CT]] [[attenuation]] values (>20 HU) and enhancement with [[Contrast medium|intravenous contrast]] on [[Computed tomography|CT]] | |||
* Delay in [[contrast medium]] washout (10 minutes after administration of contrast, an absolute [[contrast medium]] washout of less than 50 percent) | |||
* Isointensity or slightly less intense than the [[liver]] on T1 weighted [[Magnetic resonance imaging|MRI]] and high to intermediate signal intensity on T2 weighted [[Magnetic resonance imaging|MRI]] (representing an increased water content) | |||
* Elevated standardized uptake value on [[FDG-PET|FDG]]-[[PET scan]] | |||
| | |||
|} | |||
{| class="wikitable" | |||
! rowspan="2" |S.No. | |||
! rowspan="2" |Disease | |||
! colspan="3" |Symptoms | |||
! colspan="2" |Signs | |||
! colspan="3" |Diagnosis | |||
! rowspan="2" |Comments | |||
|- | |||
!Abdominal Pain | |||
!Hematuria | |||
!Headache | |||
!Abdominal mass | |||
!Abdominal tenderness | |||
!Ultrasonography | |||
!CT scan | |||
!Histology | |||
|- | |||
|1. | |||
|[[Wilms' tumor|Wilms tumor]] | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+ </nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
| | |||
*It is the best initial diagnostic study used in cases suspected with [[Wilms tumor]]. | |||
*[[Ultrasonography]] can help identify the mass as a kidney mass. | |||
*It can distinguish [[tumor]] mass from other causes of renal swelling like [[hydronephrosis]].<ref name="pmid61529362">{{cite journal |vauthors=Hartman DS, Sanders RC |title=Wilms' tumor versus neuroblastoma: usefulness of ultrasound in differentiation |journal=J Ultrasound Med |volume=1 |issue=3 |pages=117–22 |date=April 1982 |pmid=6152936 |doi= |url=}}</ref> | |||
*[[Doppler ultrasonography]] can help to detect invasion of [[renal vein]] and [[Inferior vena cava|IVC]] by the tumor.<ref name="pmid30036602">{{cite journal |vauthors=De Campo JF |title=Ultrasound of Wilms' tumor |journal=Pediatr Radiol |volume=16 |issue=1 |pages=21–4 |date=1986 |pmid=3003660 |doi= |url=}}</ref> | |||
| | |||
*Findings on [[CT scan]] which can be suggestive of [[Wilms tumor]] include:<ref name="pmid4080660">{{cite journal |vauthors=Cahan LD |title=Failure of encephalo-duro-arterio-synangiosis procedure in moyamoya disease |journal=Pediatr Neurosci |volume=12 |issue=1 |pages=58–62 |date=1985 |pmid=4080660 |doi= |url=}}</ref> | |||
**Heterogeneous soft-tissue density masses | |||
**These masses have frequent areas of [[calcification]] (~10%) and fat-density regions | |||
**[[Lymph node]] metastasis | |||
*[[CT scan]] of the renal mass can further reveal: | |||
**Invasion of surrounding organs | |||
**[[Thrombus]] in or occlusion of the [[renal vein]] and/or the [[inferior vena cava]] | |||
**Abdominal lymph nodes and contralateral involvement | |||
| | |||
*Wilms tumor has a triphasic appearance. | |||
*It is comprised of 3 types of cells: | |||
**[[Stromal]] | |||
**[[Epithelium|Epithelial]] | |||
**[[Blastema|Blastemal]] | |||
*All the 3 types are not required for the diagnosis of Wilms tumor. | |||
*Primitive tubules and [[Glomerulus|glomeruli]] are often seen comprised of [[Cancer|neoplastic]] cells. | |||
*Beckwith and Palmer reported in NWTS the different histopathologic types of Wilms tumor to categorize them based on prognosis.<ref name="pmid1978">{{cite journal |vauthors=Jolly RD, Stellwagen E, Babul J, Vodkaĭlo LV, Titov VL, Moldomusaev DM, Maianskiĭ AN |title=Mannosidosis of Angus Cattle: a prototype control program for some genetic diseases |journal=Adv Vet Sci Comp Med |volume=19 |issue=23 |pages=1–21 |date=November 1975 |pmid=1978 |doi= |url=}}</ref> | |||
*Spindled cell [[stroma]] surrounding abortive tubules and [[Glomerulus|glomeruli]] is characteristic. | |||
*The stroma may include: | |||
**Striated [[muscle]] [[cartilage]] | |||
**[[bone]] | |||
**[[Adipose tissue|Fat tissue]] | |||
**[[Fibrous connective tissue|Fibrous tissue.]] | |||
| | |||
|- | |||
|2. | |||
|[[Renal cell carcinoma]] | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>-</nowiki> | |||
| | |||
* [[Ultrasound]] (US) may be helpful when CT scan results are equivocal. It is noteworthy to mention that not all renal cell [[carcinomas]] are detectable on [[ultrasound]]. | |||
|Both [[CT]] and [[MRI]] may be used to detect [[neoplastic]] masses that may define renal cell carcinoma or metastasis of the primary cancer. [[CT]] scan and use of intravenous (IV) contrast is generally used for work-up and follow-up of patients with [[Renal cell carcinoma|renal cell carcinom]]<nowiki/>a. | |||
|The histological pattern of renal cell [[carcinoma]] depends whether it is [[Papillary|papillary,]] [[chromophobe]] or [[collecting duct]] renal cell carcinoma. | |||
| | |||
|- | |||
|3. | |||
|[[Malignant rhabdoid tumor|Rhabdoid kidney disease]] | |||
| + | |||
|<nowiki>+</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>-</nowiki> | |||
| | |||
* [[Ultrasound]] shows a complex cystic mass. | |||
| | |||
* [[CT]] scan may be diagnostic of malignant rhabdoid tumor. Findings on [[CT]] scan suggestive of malignant rhabdoid tumor include a large, heterogenous, centrally located mass, which is lobulated with individual lobules separated by intervening areas of decreased attenuation, relating to either previous [[hemorrhage]] or [[necrosis]]. Enhancement is similarly heterogeneous. [[Calcification]] is relatively common, observed in 20-50% of cases and is typically linear and tends to outline tumor [[lobules]]. | |||
| | |||
* [[Malignant]] rhabdoid tumor is characterized by the round blue tumor cells of high cellularity composed of atypical cells with eccentric nuclei, small nucleoli, and abundant amounts of [[eosinophilic]] cytoplasm with frequent mitotic figures. | |||
| | |||
|- | |||
|4. | |||
|[[Polycystic kidney disease]] | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+ (from hypertension)</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>-</nowiki> | |||
| | |||
Ultrasound may be helpful in the diagnosis of polycystic kidney disease. Findings on an ultrasound diagnostic of polycystic kidney disease include:<ref name="pmid25786098">{{cite journal |vauthors=Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T, Horie S, Kasiske BL, Odland D, Pei Y, Perrone RD, Pirson Y, Schrier RW, Torra R, Torres VE, Watnick T, Wheeler DC |title=Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference |journal=Kidney Int. |volume=88 |issue=1 |pages=17–27 |date=July 2015 |pmid=25786098 |pmc=4913350 |doi=10.1038/ki.2015.59 |url=}}</ref><ref name="pmid18945943">{{cite journal |vauthors=Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, Parfrey P, Cramer B, Coto E, Torra R, San Millan JL, Gibson R, Breuning M, Peters D, Ravine D |title=Unified criteria for ultrasonographic diagnosis of ADPKD |journal=J. Am. Soc. Nephrol. |volume=20 |issue=1 |pages=205–12 |date=January 2009 |pmid=18945943 |pmc=2615723 |doi=10.1681/ASN.2008050507 |url=}}</ref> | |||
*At least three unilateral or bilateral [[cysts]] in patients 15 - 39 years old | |||
*Atleast two [[cysts]] in each [[kidney]] in patients 40 - 59 years old | |||
*Atleast four [[cysts]] in each [[kidney]] in patients 60 years of age or older | |||
| | |||
[[Renal]] CT scan may be helpful in the diagnosis of polycystic kidney disease. Findings on CT scan diagnostic of ADPKD include: | |||
* Numerous [[renal]] [[cysts]] of varying size and shape with little intervening [[parenchyma]] with water [[attenuation]] and very thin wall. | |||
* Reduction in [[sinus]] [[fat]] due to expansion of the [[cortex]] | |||
* Occasional complex [[cysts]] with hyperdense appearance, with possible septations or calcifications | |||
* Multiple [[homogeneous]] and hypoattenuating [[cystic]] lesions in the [[liver]] in patients with [[liver]] involvement | |||
| | |||
*On microscopic histopathological analysis, interstitial fibrosis, tubular atrophy, thickening and lamellation of tubular basement membranes, microcysts and negative immunofluorescence for complement and immunoglobulin are characteristic findings of ADPKD.<ref name="pmid12234310">{{cite journal |vauthors=Stavrou C, Koptides M, Tombazos C, Psara E, Patsias C, Zouvani I, Kyriacou K, Hildebrandt F, Christofides T, Pierides A, Deltas CC |title=Autosomal-dominant medullary cystic kidney disease type 1: clinical and molecular findings in six large Cypriot families |journal=Kidney Int. |volume=62 |issue=4 |pages=1385–94 |date=October 2002 |pmid=12234310 |doi=10.1111/j.1523-1755.2002.kid581.x |url=}}</ref><ref name="pmid24509297">{{cite journal |vauthors=Bleyer AJ, Kmoch S, Antignac C, Robins V, Kidd K, Kelsoe JR, Hladik G, Klemmer P, Knohl SJ, Scheinman SJ, Vo N, Santi A, Harris A, Canaday O, Weller N, Hulick PJ, Vogel K, Rahbari-Oskoui FF, Tuazon J, Deltas C, Somers D, Megarbane A, Kimmel PL, Sperati CJ, Orr-Urtreger A, Ben-Shachar S, Waugh DA, McGinn S, Bleyer AJ, Hodanová K, Vylet'al P, Živná M, Hart TC, Hart PS |title=Variable clinical presentation of an MUC1 mutation causing medullary cystic kidney disease type 1 |journal=Clin J Am Soc Nephrol |volume=9 |issue=3 |pages=527–35 |date=March 2014 |pmid=24509297 |pmc=3944763 |doi=10.2215/CJN.06380613 |url=}}</ref><ref name="pmid21775974">{{cite journal |vauthors=Faguer S, Decramer S, Chassaing N, Bellanné-Chantelot C, Calvas P, Beaufils S, Bessenay L, Lengelé JP, Dahan K, Ronco P, Devuyst O, Chauveau D |title=Diagnosis, management, and prognosis of HNF1B nephropathy in adulthood |journal=Kidney Int. |volume=80 |issue=7 |pages=768–76 |date=October 2011 |pmid=21775974 |doi=10.1038/ki.2011.225 |url=}}</ref><ref name="pmid20378641">{{cite journal |vauthors=Heidet L, Decramer S, Pawtowski A, Morinière V, Bandin F, Knebelmann B, Lebre AS, Faguer S, Guigonis V, Antignac C, Salomon R |title=Spectrum of HNF1B mutations in a large cohort of patients who harbor renal diseases |journal=Clin J Am Soc Nephrol |volume=5 |issue=6 |pages=1079–90 |date=June 2010 |pmid=20378641 |pmc=2879303 |doi=10.2215/CJN.06810909 |url=}}</ref> | |||
| | |||
|- | |||
|5. | |||
|[[Pheochromocytoma]] | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>+ (as a part of the hypertension paroxysm)</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
| | |||
* CT is the preferred imaging modality for the diagnosis of pheochromocytoma. | |||
|The following findings may be observed on [[CT scan]]:<ref name="pmid1787652">{{cite journal| author=Bravo EL| title=Pheochromocytoma: new concepts and future trends. | journal=Kidney Int | year= 1991 | volume= 40 | issue= 3 | pages= 544-56 | pmid=1787652 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1787652 }}</ref> | |||
*Most common extra-[[Adrenal gland|adrenal]] locations are superior and inferior [[abdominal]] [[Paraaortic lymph node|paraaortic]] areas, the [[urinary bladder]], [[thorax]], [[head]], [[neck]] and [[pelvis]].<ref name="pmid1729490">{{cite journal| author=Whalen RK, Althausen AF, Daniels GH| title=Extra-adrenal pheochromocytoma. | journal=J Urol | year= 1992 | volume= 147 | issue= 1 | pages= 1-10 | pmid=1729490 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1729490 }}</ref> | |||
*In sporadic pheochromocytoma, [[CT]] and [[MRI]] are good choices. The choice depends on availability and cost.<ref name="pmid191248172">{{cite journal| author=Baid SK, Lai EW, Wesley RA, Ling A, Timmers HJ, Adams KT et al.| title=Brief communication: radiographic contrast infusion and catecholamine release in patients with pheochromocytoma. | journal=Ann Intern Med | year= 2009 | volume= 150 | issue= 1 | pages= 27-32 | pmid=19124817 | doi= | pmc=3490128 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19124817 }}</ref> | |||
*In patients with the [[multiple endocrine neoplasia]] type 2 ([[Multiple endocrine neoplasia type 2|MEN2]]) syndrome, [[CT]] may miss the [[tumors]].<ref name="pmid17876522">{{cite journal| author=Bravo EL| title=Pheochromocytoma: new concepts and future trends. | journal=Kidney Int | year= 1991 | volume= 40 | issue= 3 | pages= 544-56 | pmid=1787652 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1787652 }}</ref> | |||
| | |||
* On microscopic pathology, [[Pheochromocytoma]] typically demonstrates a nesting (Zellballen) pattern on microscopy. This pattern is composed of well-defined clusters of tumor cells containing [[eosinophilic]] cytoplasm separated by fibrovascular [[stroma]]. | |||
| | |||
|- | |||
|6. | |||
|[[Burkitt's lymphoma|Burkitt lymphoma]] | |||
|<nowiki>+/- (in non-endemic or sporadic form of the disease)</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
| | |||
* Abdominal [[ultrasonography]] may show [[splenomegaly]] and [[ascites]]. | |||
| | |||
* Chest, abdomen, and pelvis [[CT]] scan may be helpful in the diagnosis of [[Burkitt's lymphoma]] but it is not done routinely.<ref name="medlineplus">Burkitt lymphoma. MedlinePlus. https://www.nlm.nih.gov/medlineplus/ency/article/001308.htm Accessed on September 30, 2015</ref> | |||
| | |||
*On microscopic histopathological analysis, characteristic findings of Burkitt's lymphoma include:<ref name="pmid12610094">{{cite journal |author=Bellan C, Lazzi S, De Falco G, Nyongo A, Giordano A, Leoncini L |title=Burkitt's lymphoma: new insights into molecular pathogenesis |journal=J. Clin. Pathol. |volume=56 |issue=3 |pages=188–92 |year=2003 |month=March |pmid=12610094 |pmc=1769902 |doi= |url=http://jcp.bmj.com/cgi/pmidlookup?view=long&pmid=12610094}}</ref> | |||
:*Medium-sized (~1.5-2x the size of a RBC) with uniform size ("monotonous") -- '''key feature''' (i.e. tumor nuclei size similar to that of [[histiocytes]] or [[endothelial cells]]) | |||
:*Round nucleus | |||
:*Small nucleoli | |||
:*Relatively abundant cytoplasm ([[basophilic]]) | |||
:*Brisk mitotic rate and [[apoptotic]] activity | |||
:*Cellular outline usually appears squared off | |||
:*"Starry-sky pattern": | |||
::*The ''stars'' in the pattern are tingible-body macrophages (macrophages containing [[apoptotic]] tumor cells. | |||
::*The tumour cells are the ''sky'' | |||
| | |||
|- | |||
|7. | |||
|[[Intussusception]] | |||
|<nowiki>+</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>+/- </nowiki> | |||
|<nowiki>+</nowiki> | |||
| | |||
* [[Ultrasound]] is the [[Gold standard (test)|gold standard]] imaging modality used to diagnose intussusception<ref name="pmid17308922">{{cite journal |vauthors=Ko HS, Schenk JP, Tröger J, Rohrschneider WK |title=Current radiological management of intussusception in children |journal=Eur Radiol |volume=17 |issue=9 |pages=2411–21 |year=2007 |pmid=17308922 |doi=10.1007/s00330-007-0589-y |url=}}</ref> | |||
**Target or doughnut sign<ref name="pmid8470658">{{cite journal |vauthors=Boyle MJ, Arkell LJ, Williams JT |title=Ultrasonic diagnosis of adult intussusception |journal=Am. J. Gastroenterol. |volume=88 |issue=4 |pages=617–8 |year=1993 |pmid=8470658 |doi= |url=}}</ref> | |||
***Edematous intussuscipien forms an external ring around the centrally located intussusceptum | |||
***Target sign is usually seen in right lower quadrant | |||
**Layers of intussusception forms pseudo-kidney appearance on the transverse view | |||
| | |||
* [[Computed tomography|CT scan]] may be helpful in the [[diagnosis]] of intussusception. [[Computed tomography|CT scan]] maybe used when other image modalities like [[x-ray]] and [[ultrasound]] have not given positive results but suspicion of intussusception is high. | |||
| | |||
* Intussusception occurs if there is an imbalance between the longitudinal and radial [[smooth muscle]] forces of [[intestine]] that maintain its normal structure. This imbalance leads to a segment of [[intestine]] to invaginate into another segment and cause entero-enteral intussusception. [[Etiology]] of intussusception is either idiopathic or [[Pathology|pathologic]] (lead point). | |||
| | |||
|- | |||
|8. | |||
|[[Hydronephrosis]] | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>+ (CVA tenderness in case of pyelonephritis)</nowiki> | |||
| | |||
* [[Ultrasound]] allows for visualization of the [[ureters]] and [[kidneys]] and can be used to assess the presence of [[hydronephrosis]] and/or [[hydroureter]]. | |||
| | |||
* In the case of [[renal colic]] (one sided loin pain usually accompanied by a trace of blood in the urine) the initial investigation is usually an intravenous urogram. This has the advantage of showing whether there is any obstruction of flow of urine causing [[hydronephrosis]] as well as demonstrating the function of the other kidney. Many [[Stones- kidney|stones]] are not visible on [[X ray|plain x ray]] or IVU but 99% of [[Stones- kidney|stones]] are visible on [[CT]] and therefore CT is becoming a common choice of initial investigation. | |||
| | |||
* The kidney undergoes extensive dilation with atrophy and thinning of the renal cortex. | |||
| | |||
|- | |||
|9. | |||
|[[Dysplasia|Dysplastic kidney]] | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
| | |||
MCDK is usually diagnosed by [[ultrasound]] examination before birth. | |||
* Mass of non-communicating cysts of variable size. | |||
* Unlike severe [[hydronephrosis]], in which the largest cystic structure (the renal pelvis) lies in a central location and is surrounded by dilated calices, in multicystic dysplastic kidney the cyst distribution shows no recognizable pattern. | |||
* [[Dysplasia|Dysplastic]], echogenic [[parenchyma]] may be visible between the cysts, but no normal renal parenchyma is seen. | |||
| | |||
* MCKD can be discovered accidentally on [[CT]] scan. | |||
* [[CT scan]] shows myltiple cysts with absence of renal parenchyma. | |||
| | |||
* MCKD is the result of abnormal differentiation of the renal parenchyma. | |||
| | |||
|- | |||
|10. | |||
|[[Neuroblastoma|Pediatric Neuroblastoma]] | |||
|<nowiki>+</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
| | |||
* On ultrasound, neuroblastoma is characterized by a heterogeneous [[echogenicity]] due to the [[vascular]], [[necrotic]], and calcified content of the mass.<ref name="radio">Neuroblastoma. Radiopaedia (2015) http://radiopaedia.org/articles/neuroblastoma Accessed on October, 8 2015</ref> | |||
| | |||
*CT scan is the investigation of choice for the diagnosis of neuroblastoma.<ref name="pmid21736987">{{cite journal| author=Colon NC, Chung DH| title=Neuroblastoma. | journal=Adv Pediatr | year= 2011 | volume= 58 | issue= 1 | pages= 297-311 | pmid=21736987 | doi=10.1016/j.yapd.2011.03.011 | pmc=PMC3668791 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21736987 }}</ref> | |||
*On CT scan, neuroblastoma is characterized by:<ref name="radio2">Neuroblastoma. Radiopaedia (2015) http://radiopaedia.org/articles/neuroblastoma Accessed on October, 8 2015</ref> | |||
:*Heterogeneous mass | |||
:*[[Calcification]] | |||
:*[[Necrosis]] | |||
:*Compression of the surrounding vessels | |||
:*Invasion of the [[psoas]] [[muscle]] or [[kidney]]s | |||
:*Swollen [[lymph node]]s | |||
| | |||
*On microscopic histopathological analysis the presence of round blue cells separated by thin [[fibrous]] septa are characteristic findings of neuroblastoma. | |||
*Other findings of neuroblastoma on [[light microscopy]] may include:<ref name="patho">Neuroblastoma. Libre Pathology(2015) http://librepathology.org/wiki/index.php/Adrenal_gland#Neuroblastoma Accessed on October, 5 2015</ref> | |||
:*Homer-Wright rosettes (rosettes with a small meshwork of fibers at the center) | |||
:*Neuropil-like [[stroma]] (paucicellular stroma with a cotton candy-like appearance) | |||
*On [[electron microscopy]] neuroblastoma is characterized by: | |||
:*Dendritic processes with longitudinally oriented [[microtubule]]s | |||
:*Membrane bound electron-dense [[granule]]s that contain [[catecholamine]]s | |||
:*Presence of [[desmosomes]] | |||
:*Absence of [[glycogen]] | |||
| | |||
|- | |||
|11. | |||
|[[Rhabdomyosarcoma|Pediatric Rhabdomyosarcoma]] | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
| | |||
|On [[CT scan]], rhabdomyosarocma is characterized by: | |||
* Soft tissue density | |||
* Some enhancement with [[contrast]] | |||
* Adjacent bony destruction (over 20% of cases) | |||
| | |||
* Rhadbomyosarcoma has an appearance similar to the other round blue cell tumors such as [[Ewing sarcoma]] and [[Osteoblastoma|small cell osteoblastoma]]. | |||
| | |||
|- | |||
|12. | |||
|[[Mesoblastic nephroma]] | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>-</nowiki> | |||
| | |||
*[[Ultrasound]] may be helpful in the diagnosis of mesoblastic nephroma. | |||
*Mesoblastic nephroma may presents as a well-defined [[mass]] with low-level homogeneous echoes.<ref name="radio3">Mesoblastic nephroma.Dr Ayush Goel and Dr Yuranga Weerakkody et al. Radiopaedia.org 2015. http://radiopaedia.org/articles/mesoblastic-nephroma</ref> | |||
*The presence of concentric echogenic and hypoechoic rings can be a helpful diagnostic feature of [[mesoblastic nephroma]]. | |||
| | |||
* [[CT scan]] may be helpful in the diagnosis of mesoblastic nephroma. | |||
* Findings on CT scan suggestive of mesoblastic nephroma include: | |||
:* Solid hypoattenuating renal lesion | |||
:* Variable contrast enhancement | |||
:* No [[calcification]] | |||
| | |||
Classic mesoblastic nephroma | |||
* [[Spindle cells]] in [[fascicles]] | |||
* Infiltrative border | |||
Cellular mesoblastic nephroma | |||
* Plump cells with vesicular nuclei | |||
* Well-defined border | |||
* Mitotically active | |||
Mixed mesoblastic nephroma | |||
* Both classic pattern and cellular pattern areas are present | |||
|Most common renal tumor that occurs in 1st month of life | |||
|} | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Latest revision as of 19:31, 25 February 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2] Mohammed Abdelwahed M.D[3]
Overview
Pheochromocytoma must be differentiated from other causes of paroxysmal hypertension including severe paroxysmal hypertension (pseudopheochromocytoma), panic disorder, factitious hypertension, carcinoid syndrome, migraine headache, hyperthyroidism, renovascular hypertension, hypoglycemia, labile hypertension (White coat hypertension), stroke, compression of the lateral medulla, seizures, baroreflex failure and drugs.
Differentiating pheochromocytoma from other diseases
Pheochromocytoma must be differentiated from other causes of paroxysmal hypertension. The differentials include:
Disease | Symptoms | Signs | Investigations |
---|---|---|---|
Pheochromocytoma[1][4] | Features of sympathetic nervous systemhyperactivity and include:
|
|
|
Pseudopheochromocytoma (idiopathic)[1][2][3][4] | Paroxysmal activation of the sympathetic system may cause:
|
| |
Panic attacks |
|
|
Laboratory studies that can exclude medical disorders other than panic disorder include: |
Labile hypertension (White coat hypertension) |
|
Elevated blood pressure, tachycardia, and may be anxiety in a clinical setting but not in other settings[1] |
|
Hyperthyroidism |
|
|
|
Renovascular hypertension |
|
| |
Stroke and compression of lateral medulla (Lateral medullary syndrome) |
|
|
|
Seizures | According to type; it may be focal or generalized, clinical or subclinical:[7]
|
|
|
Carcinoid syndrome | Hypertensive crisis occurs with malignant carcinoid syndrome[10]. Symptoms include:
|
| |
Migraine headaches |
|
|
CT is indicated in patients with:[1][2]
CT is not indicated in:
|
Drugs | Sympathomimetic drugs that can induce symptoms simulating pheochromocytoma include:
|
|
|
Baroreflex failure[18] |
|
|
|
Pheochromocytoma must be differentiated from other adrenal tumors such as adrenocortical adenoma, adrenal metastasis, and Cushing's syndrome.
Differential Diagnosis | Clinical picture | Imagings | Laboratory tests |
---|---|---|---|
Adrenocortical carcinoma |
|
|
|
Adrenal adenoma |
|
|
|
Cushing's syndrome |
|
|
|
Pheochromocytoma |
|
|
|
Adrenal metastasis |
|
|
S.No. | Disease | Symptoms | Signs | Diagnosis | Comments | |||||
---|---|---|---|---|---|---|---|---|---|---|
Abdominal Pain | Hematuria | Headache | Abdominal mass | Abdominal tenderness | Ultrasonography | CT scan | Histology | |||
1. | Wilms tumor | + | + | - | + | + |
|
|
|
|
2. | Renal cell carcinoma | + | + | +/- | + | - |
|
Both CT and MRI may be used to detect neoplastic masses that may define renal cell carcinoma or metastasis of the primary cancer. CT scan and use of intravenous (IV) contrast is generally used for work-up and follow-up of patients with renal cell carcinoma. | The histological pattern of renal cell carcinoma depends whether it is papillary, chromophobe or collecting duct renal cell carcinoma. | |
3. | Rhabdoid kidney disease | + | + | - | + | - |
|
|
|
|
4. | Polycystic kidney disease | + | + | + (from hypertension) | + | - |
Ultrasound may be helpful in the diagnosis of polycystic kidney disease. Findings on an ultrasound diagnostic of polycystic kidney disease include:[25][26] |
Renal CT scan may be helpful in the diagnosis of polycystic kidney disease. Findings on CT scan diagnostic of ADPKD include:
|
||
5. | Pheochromocytoma | - | - | + (as a part of the hypertension paroxysm) | - | - |
|
The following findings may be observed on CT scan:[31]
|
|
|
6. | Burkitt lymphoma | +/- (in non-endemic or sporadic form of the disease) | - | - | - | - |
|
|
|
|
7. | Intussusception | + | - | - | +/- | + |
|
|
|
|
8. | Hydronephrosis | + | +/- | - | - | + (CVA tenderness in case of pyelonephritis) |
|
|
|
|
9. | Dysplastic kidney | N/A | N/A | N/A | N/A | N/A |
MCDK is usually diagnosed by ultrasound examination before birth.
|
|
||
10. | Pediatric Neuroblastoma | + | - | - | +/- | +/- |
|
|
|
|
11. | Pediatric Rhabdomyosarcoma | + | +/- | +/- | - | +/- | On CT scan, rhabdomyosarocma is characterized by:
|
|
||
12. | Mesoblastic nephroma | + | + | - | + | - |
|
|
Classic mesoblastic nephroma
Cellular mesoblastic nephroma
Mixed mesoblastic nephroma
|
Most common renal tumor that occurs in 1st month of life |
References
- ↑ Mann SJ (1999). "Severe paroxysmal hypertension (pseudopheochromocytoma): understanding the cause and treatment". Arch Intern Med. 159 (7): 670–4. PMID 10218745.
- ↑ Mann SJ (1999). "Severe paroxysmal hypertension (pseudopheochromocytoma): understanding the cause and treatment". Arch Intern Med. 159 (7): 670–4. PMID 10218745.
- ↑ Mann SJ (1996). "Severe paroxysmal hypertension. An automatic syndrome and its relationship to repressed emotions". Psychosomatics. 37 (5): 444–50. doi:10.1016/S0033-3182(96)71532-3. PMID 8824124.
- ↑ Sharabi Y, Goldstein DS, Bentho O, Saleem A, Pechnik S, Geraci MF; et al. (2007). "Sympathoadrenal function in patients with paroxysmal hypertension: pseudopheochromocytoma". J Hypertens. 25 (11): 2286–95. doi:10.1097/HJH.0b013e3282ef5fac. PMID 17921824.
- ↑ Iglesias P, Acosta M, Sánchez R, Fernández-Reyes MJ, Mon C, Díez JJ (2005). "Ambulatory blood pressure monitoring in patients with hyperthyroidism before and after control of thyroid function". Clin Endocrinol (Oxf). 63 (1): 66–72. doi:10.1111/j.1365-2265.2005.02301.x. PMID 15963064.
- ↑ Mintz G, Pizzarello R, Klein I (1991). "Enhanced left ventricular diastolic function in hyperthyroidism: noninvasive assessment and response to treatment". J Clin Endocrinol Metab. 73 (1): 146–50. doi:10.1210/jcem-73-1-146. PMID 2045465.
- ↑ 7.0 7.1 Mintz G, Pizzarello R, Klein I (1991). "Enhanced left ventricular diastolic function in hyperthyroidism: noninvasive assessment and response to treatment". J Clin Endocrinol Metab. 73 (1): 146–50. doi:10.1210/jcem-73-1-146. PMID 2045465.
- ↑ Brigo F, Storti M, Lochner P, Tezzon F, Fiaschi A, Bongiovanni LG; et al. (2012). "Tongue biting in epileptic seizures and psychogenic events: an evidence-based perspective". Epilepsy Behav. 25 (2): 251–5. doi:10.1016/j.yebeh.2012.06.020. PMID 23041172.
- ↑ Fountain NB, Van Ness PC, Swain-Eng R, Tonn S, Bever CT, American Academy of Neurology Epilepsy Measure Development Panel and the American Medical Association-Convened Physician Consortium for Performance Improvement Independent Measure Development Process (2011). "Quality improvement in neurology: AAN epilepsy quality measures: Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology". Neurology. 76 (1): 94–9. doi:10.1212/WNL.0b013e318203e9d1. PMID 21205698.
- ↑ Warner RR, Mani S, Profeta J, Grunstein E (1994). "Octreotide treatment of carcinoid hypertensive crisis". Mt Sinai J Med. 61 (4): 349–55. PMID 7969229.
- ↑ Sjöblom SM (1988). "Clinical presentation and prognosis of gastrointestinal carcinoid tumours". Scand J Gastroenterol. 23 (7): 779–87. PMID 3227292.
- ↑ Feldman JM (1986). "Urinary serotonin in the diagnosis of carcinoid tumors". Clin Chem. 32 (5): 840–4. PMID 2421946.
- ↑ Eriksson B, Arnberg H, Oberg K, Hellman U, Lundqvist G, Wernstedt C; et al. (1990). "A polyclonal antiserum against chromogranin A and B--a new sensitive marker for neuroendocrine tumours". Acta Endocrinol (Copenh). 122 (2): 145–55. PMID 2316306.
- ↑ Sundin A, Vullierme MP, Kaltsas G, Plöckinger U, Mallorca Consensus Conference participants. European Neuroendocrine Tumor Society (2009). "ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: radiological examinations". Neuroendocrinology. 90 (2): 167–83. doi:10.1159/000184855. PMID 19077417.
- ↑ Kelman L (2004). "The premonitory symptoms (prodrome): a tertiary care study of 893 migraineurs". Headache. 44 (9): 865–72. doi:10.1111/j.1526-4610.2004.04168.x. PMID 15447695.
- ↑ Krentz AJ, Mikhail S, Cantrell P, Hill GM (2001). "Drug Points: Pseudophaeochromocytoma syndrome associated with clozapine". BMJ. 322 (7296): 1213. PMC 31620. PMID 11358774.
- ↑ Kuchel O (1985). "Pseudopheochromocytoma". Hypertension. 7 (1): 151–8. PMID 3980057.
- ↑ Robertson D, Hollister AS, Biaggioni I, Netterville JL, Mosqueda-Garcia R, Robertson RM (1993). "The diagnosis and treatment of baroreflex failure". N Engl J Med. 329 (20): 1449–55. doi:10.1056/NEJM199311113292003. PMID 8413455.
- ↑ 19.0 19.1 Zar T, Peixoto AJ (2008). "Paroxysmal hypertension due to baroreflex failure". Kidney Int. 74 (1): 126–31. doi:10.1038/ki.2008.30. PMID 18322544.
- ↑ Manolopoulou J, Fischer E, Dietz A, Diederich S, Holmes D, Junnila R; et al. (2015). "Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassays". J Hypertens. 33 (12): 2500–11. doi:10.1097/HJH.0000000000000727. PMID 26372319.
- ↑ Hartman DS, Sanders RC (April 1982). "Wilms' tumor versus neuroblastoma: usefulness of ultrasound in differentiation". J Ultrasound Med. 1 (3): 117–22. PMID 6152936.
- ↑ De Campo JF (1986). "Ultrasound of Wilms' tumor". Pediatr Radiol. 16 (1): 21–4. PMID 3003660.
- ↑ Cahan LD (1985). "Failure of encephalo-duro-arterio-synangiosis procedure in moyamoya disease". Pediatr Neurosci. 12 (1): 58–62. PMID 4080660.
- ↑ Jolly RD, Stellwagen E, Babul J, Vodkaĭlo LV, Titov VL, Moldomusaev DM, Maianskiĭ AN (November 1975). "Mannosidosis of Angus Cattle: a prototype control program for some genetic diseases". Adv Vet Sci Comp Med. 19 (23): 1–21. PMID 1978.
- ↑ Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T, Horie S, Kasiske BL, Odland D, Pei Y, Perrone RD, Pirson Y, Schrier RW, Torra R, Torres VE, Watnick T, Wheeler DC (July 2015). "Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference". Kidney Int. 88 (1): 17–27. doi:10.1038/ki.2015.59. PMC 4913350. PMID 25786098.
- ↑ Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, Parfrey P, Cramer B, Coto E, Torra R, San Millan JL, Gibson R, Breuning M, Peters D, Ravine D (January 2009). "Unified criteria for ultrasonographic diagnosis of ADPKD". J. Am. Soc. Nephrol. 20 (1): 205–12. doi:10.1681/ASN.2008050507. PMC 2615723. PMID 18945943.
- ↑ Stavrou C, Koptides M, Tombazos C, Psara E, Patsias C, Zouvani I, Kyriacou K, Hildebrandt F, Christofides T, Pierides A, Deltas CC (October 2002). "Autosomal-dominant medullary cystic kidney disease type 1: clinical and molecular findings in six large Cypriot families". Kidney Int. 62 (4): 1385–94. doi:10.1111/j.1523-1755.2002.kid581.x. PMID 12234310.
- ↑ Bleyer AJ, Kmoch S, Antignac C, Robins V, Kidd K, Kelsoe JR, Hladik G, Klemmer P, Knohl SJ, Scheinman SJ, Vo N, Santi A, Harris A, Canaday O, Weller N, Hulick PJ, Vogel K, Rahbari-Oskoui FF, Tuazon J, Deltas C, Somers D, Megarbane A, Kimmel PL, Sperati CJ, Orr-Urtreger A, Ben-Shachar S, Waugh DA, McGinn S, Bleyer AJ, Hodanová K, Vylet'al P, Živná M, Hart TC, Hart PS (March 2014). "Variable clinical presentation of an MUC1 mutation causing medullary cystic kidney disease type 1". Clin J Am Soc Nephrol. 9 (3): 527–35. doi:10.2215/CJN.06380613. PMC 3944763. PMID 24509297.
- ↑ Faguer S, Decramer S, Chassaing N, Bellanné-Chantelot C, Calvas P, Beaufils S, Bessenay L, Lengelé JP, Dahan K, Ronco P, Devuyst O, Chauveau D (October 2011). "Diagnosis, management, and prognosis of HNF1B nephropathy in adulthood". Kidney Int. 80 (7): 768–76. doi:10.1038/ki.2011.225. PMID 21775974.
- ↑ Heidet L, Decramer S, Pawtowski A, Morinière V, Bandin F, Knebelmann B, Lebre AS, Faguer S, Guigonis V, Antignac C, Salomon R (June 2010). "Spectrum of HNF1B mutations in a large cohort of patients who harbor renal diseases". Clin J Am Soc Nephrol. 5 (6): 1079–90. doi:10.2215/CJN.06810909. PMC 2879303. PMID 20378641.
- ↑ Bravo EL (1991). "Pheochromocytoma: new concepts and future trends". Kidney Int. 40 (3): 544–56. PMID 1787652.
- ↑ Whalen RK, Althausen AF, Daniels GH (1992). "Extra-adrenal pheochromocytoma". J Urol. 147 (1): 1–10. PMID 1729490.
- ↑ Baid SK, Lai EW, Wesley RA, Ling A, Timmers HJ, Adams KT; et al. (2009). "Brief communication: radiographic contrast infusion and catecholamine release in patients with pheochromocytoma". Ann Intern Med. 150 (1): 27–32. PMC 3490128. PMID 19124817.
- ↑ Bravo EL (1991). "Pheochromocytoma: new concepts and future trends". Kidney Int. 40 (3): 544–56. PMID 1787652.
- ↑ Burkitt lymphoma. MedlinePlus. https://www.nlm.nih.gov/medlineplus/ency/article/001308.htm Accessed on September 30, 2015
- ↑ Bellan C, Lazzi S, De Falco G, Nyongo A, Giordano A, Leoncini L (2003). "Burkitt's lymphoma: new insights into molecular pathogenesis". J. Clin. Pathol. 56 (3): 188–92. PMC 1769902. PMID 12610094. Unknown parameter
|month=
ignored (help) - ↑ Ko HS, Schenk JP, Tröger J, Rohrschneider WK (2007). "Current radiological management of intussusception in children". Eur Radiol. 17 (9): 2411–21. doi:10.1007/s00330-007-0589-y. PMID 17308922.
- ↑ Boyle MJ, Arkell LJ, Williams JT (1993). "Ultrasonic diagnosis of adult intussusception". Am. J. Gastroenterol. 88 (4): 617–8. PMID 8470658.
- ↑ Neuroblastoma. Radiopaedia (2015) http://radiopaedia.org/articles/neuroblastoma Accessed on October, 8 2015
- ↑ Colon NC, Chung DH (2011). "Neuroblastoma". Adv Pediatr. 58 (1): 297–311. doi:10.1016/j.yapd.2011.03.011. PMC 3668791. PMID 21736987.
- ↑ Neuroblastoma. Radiopaedia (2015) http://radiopaedia.org/articles/neuroblastoma Accessed on October, 8 2015
- ↑ Neuroblastoma. Libre Pathology(2015) http://librepathology.org/wiki/index.php/Adrenal_gland#Neuroblastoma Accessed on October, 5 2015
- ↑ Mesoblastic nephroma.Dr Ayush Goel and Dr Yuranga Weerakkody et al. Radiopaedia.org 2015. http://radiopaedia.org/articles/mesoblastic-nephroma